Abstract:AIM:To evaluate the efficacy and safety of transcatheter arterial chemoembolization（TACE） for gastrointestinal stromal tumor（GIST） with liver metastases after the failure of tyrosine kinase inhibitors（TKIs）.METHODS:Patients with histologically confirmed CD117-positive GIST with liver metastases who were resistant and/or intolerant to prior imatinib and/or sunitinib and who received TACE for at least one treatment cycle or only best supportive care and TKI reintroduction were eligible for the study.The patients were divided into two groups:those in TACE group received TACE treatment containing 5-20 mL iodized oil and 40-80 mg doxorubicin hydrochloride and TKI reintroduction or best supportive care,those in control group only received TKI reintroduction or best supportive care.The primary end-point was overall survival and the secondary end-points were,progression-free survival（PFS）,response rates,and safety.RESULTS:Sixty patients admitted between June 2008 and October 2011 were eligible for this study,including 22 in TACE group and 38 in control group.In the TACE group,12（54.5%） achieved liver partial response,5（22.7%） had stable disease,and 5（22.7%） had liver progressive disease.Disease control rate of liver metastases was 77.3% in the TACE group and 39.5% in the control group.The median liver PFS in TACE group was 47.1 wk（95% CI:23.9-70.3）.The median PFS in TACE group was longer than in control group（30.0 wk,95% CI:20.1-39.9 vs 12.9 wk,95% CI:11.9-13.9）（P = 0.0001）.The median overall survival in TACE group was also longer than in control group（68.5 wk,95% CI:57.4-79.6 vs 25.7 wk,95% CI:23.2-28.2）（P = 0.0001）.TACE treatment significantly reduced the risk of death（hazard ratio:0.109）.Patients without extrahepatic metastases treated with TACE had significantly better prognosis.Most of the adverse events were of grade 1 or 2 and tolerable.CONCLUSION:TACE is effective and well tolerated in GIST patients with liver metastases after TKI failure,and it may be an optional treatment for this disease.

Transcatheter Arterial Chemoembolization in the Treatment of Celiac Metastasis after Hepatocellular Carcinoma Rupture

Three-dimensional Conformal Radiotherapy in Combination with Transcatheter Arterial Chemoembolization in the Treatment of Hepatocellular Carcinoma.

Bile Duct Injury after Transcatheter Arterial Chemoembolization for Hepatic Carcinoma

Evaluation of the Curative Effect of Transcatheter Arterial Chemoembolization Via Hepatic Artery Combined with Percutaneous Ethanol Injection for the Treatment of Primary Hepatocellular Carcinoma

[Analysis of Clinical Prognosis and the Correlation Between Bile Duct Injury after Transcatheter Arterial Chemoembolization and the Level of Hepatic Arterial Embolization in Patients with Hepatocellular Carcinoma].

Recent Advances on Bile Duct Injury after Transcatheter Arterial Chemoembolization for Hepatic Malignancy

Retrospective Analysis of Transcatheter Arterial Chemoembolization Treatment for Spontaneously Ruptured Hepatocellular Carcinoma.

Evaluation of CT-guided ~(125)I Seed Implantation Combined with Transcatheter Arterial Chemoembolization in Treating Portal Vein Tumor Thrombus Associated with Hepatocellular Carcinoma

[Evaluation of the Efficacy and Prognostic Factors for Colorectal Liver Metastases Treated with Transcatheter Arterial Chemoembolization].

[Transcatheter Hepatic Arterial Chemoembolization on Recurrent Hepatocellular Carcinoma after Resection].

Clinical Efficacy of Transcatheter Arterial Chemoembolization Combined With Percutaneous Microwave Coagulation Therapy for Advanced Hepatocellular Carcinoma

Efficacy and Safety of Transarterial Chemoembolization with a Three-Stage Mixed Chemoembolic Regimen for Large Unresectable Hepatocellular Carcinoma.

Efficacy of transcatheter arterial chemoembolization for liver metastases arising from pancreatic cancer.

Emergency Embolization in the Treatment of Ruptured Hepatocellular Carcinoma Following Transcatheter Arterial Chemoembolization.

Efficacy and safety of transcatheter arterial chemoembolization combined with systemic chemotherapy in urothelial carcinoma patients with liver metastasis

Expression of PCNA and Nm23-H1/ndpk in Hepatocellular Carcinoma Following Transcatheter Arterial Chemoembolization Therapy

Emergency Transarterial Chemoembolization for Spontaneous Rupture and Intraperitoneal Hemorrhage of Primary Liver Cancer

Transcatheter Arterial Chemoembolization Combined with Hepatic Arterial Infusion Chemotherapy Versus Transcatheter Arterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Systematic Review and Meta-analysis

Efficacy and Safety of Transcatheter Arterial Chemoembolization and Transcatheter Arterial Chemotherapy Infusion in Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.

Transcatheter Arterial Chemoembolization for Gastrointestinal Stromal Tumors with Liver Metastases